medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2012, Número 2

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2012; 10 (2)


Subcisión en rítides glabelares

Adame MGJ, Moreno GJL

Idioma: Español
Referencias bibliográficas: 27
Paginas: 148-151
Archivo PDF: 140.91 Kb.


RESUMEN

Las expresiones faciales de la glabela, marcadas por el paso del tiempo, la radiación solar, y los movimientos musculares son un motivo frecuente de consulta. Algunos pacientes rechazan el uso de la toxina botulínica o de los materiales de relleno, por lo que proponemos la subcisión como alternativa, modificando la técnica adicionando la miotomía de los corrugadores.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Carruthers JDA, Carruthers JA. “Treatment of glabellar frown lines with C. botulinum-A exotoxin”. J Dermatol Surg Oncol 1992; 18(1): 17-21.

  2. De Boulle K, Fagien S, Sommer B, Glogau R. “Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction”. Clin Interv Aging 2010; 5: 101-118.

  3. Carruthers J, Lowe N, Menter M, et al. “A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines”. J Am Acad Dermatol 2002; 46(6): 840-849.

  4. Monheit GD, Cohen JL. “Reloxin Investigational Group Long-term safety of repeated administrations of a new formulation of botulinum toxin type A in the treatment of glabellar lines: interim analysis from an open-label extension study”. J Am Acad Dermatol 2009; 61(3): 421-425.

  5. Brandt F, Swanson N, Baumann L, Huber B. “Randomized, placebocontrolled study of a new botulinum toxin type A for treatment of glabellar lines: efficacy and safety”. Dermatol Surg 2009; 35: 1-9.

  6. Dessy LA, Fallico N, Mazzocchi M, Scuderi N. “Botulinum toxin for blabellar lines: A review of the efficacy and safety of currently available products”. Am J Clin Dermatol 2011; Aug 30. E Pub. Pendiente impresión.

  7. Kuehn B. “Studies, reports say botulinum toxins may have effects beyond injection site”. JAMA 2008; 299: 2261-2263.

  8. Cheng I, Moreno JL. “Materiales de relleno”. DCMQ, 2011; 4: 275-283

  9. Jacovella PF. “Use of calcium hydroxylapatite (Radiesse®) for facial augmentation”. Clin Interv Aging 2008; 3(1): 161-174.

  10. Castro AC, Collares MV, Portinho CP, Dias PC, Pinto RA. “Extensive facial necrosis after infiltration of polymethyl-methacrylate”. Braz J Otorhinolaryngol 2007; 73: 85

  11. K. “Arterial embolization and skin necrosis of the nasal ala following injection of dermal fillers”. Plast Reconstr Surg 2008; 121: 127e-128e.

  12. Salles AG, Lotierzo PH, Gemperli R, Besteiro JM, Ishida LC, Gimenez RP, et al. “Complications after polymethylmethacrylate injections: report on 32 cases”. Plast Reconstr Surg 2008; 121: 1811-1820.

  13. Silva MT, Curi AL. “Blindness and total ophthalmplegia after aesthetic polymethylmethacrylate injection: case report”. Arg Neuropsiquiatr 2004; 62: 873-874.

  14. Quatela VC, Choe KS. “Endobrow-midface lift”. Facial Plast Surg 2004 Aug; 20(3): 199-206.

  15. Orentreich DS, Orentreich N. “Subcutaneous incisionless (subcision) surgery for the correction of depressed scars and wrinkles”. Dermatol Surg 1995 Jun; 21(6): 543-549.

  16. Sasaki GH. “Comparison of results of wire subcision performed alone, with fills, and/or with adjacent surgical procedures”. Aesthet Surg J 2008; 28(6): 619-626.

  17. Alam M, Omura N, Kaminer MS. “Subcision for acne scarring: technique and outcomes in 40 patients”. Dermatol Surg 2005; 31: 310-317.

  18. Hexsel DM, Mazzuco R. “Subcision: a treatment for cellulite”. Int J Dermatol 2000; 39(7): 539-544.

  19. Branson DF. “Dermal undermining (scarification) of active rhytids and scars: enhancing the results of CO2 laser skin resurfacing”. Aesthet Surg J 1998; 18(1): 36-37.

  20. Luis Montoya P, Pichardo Velázquez P, HojyoTomoka MT, Domínguez Cherit J. “Evaluation of subcision as a treatment for cutaneous striae”. J Drugs Dermatol 2005; 4(3): 346-350.

  21. Hsu YJ, Chang YJ, Su LH, Hsu YL. “Using novel subcision technique for the treatment of primary essential cutis verticis gyrata”. Int J Dermatol 2009; 48(3): 307-309.

  22. Karacalar A, Demir A, Yildiz L. “Subcision surgery for the correction of ear deformities”. Aesthetic Plast Surg 2004; 28(4): 239-244.

  23. Assis Montenegro Cido Carvalho F, Vieira da Silva V Jr, Moreira AA, Viana FO. “Definitive treatment for crow’s feet wrinkles by total myectomy of the lateral Orbicularis Oculi”. Aesthetic Plast Surg 2008; 32(5): 779-782.

  24. Carruthers JD, Glogau RG, Blitzer A, Facial Aesthetics Consensus Group Faculty. “Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies –consensus recommendations”. Plast Reconstr Surg 2008; 121(5 Suppl): 5S-30S.

  25. Carruthers J, Carruthers A. “A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A”. Dermatol Surg 2003; 29(8): 802-809.

  26. McCracken MS, Khan JA, Wulc AE, et al. “Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients”. Ophthal Plast Reconstr Surg 2006 May-Jun; 22(3): 188- 191.

  27. Goodman GJ. “The use of botulinum toxin as primary or adjunctive treatment for post acne and traumatic scarring”. J Cutan Aesthet Surg 2010; 3(2): 90-92.




2020     |     www.medigraphic.com